 | • レポートコード：GIR-23F3747 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Antibody-drug Conjugates Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の抗体薬物複合体の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 抗体薬物複合体市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・アドセトリス、カドキュラ アプリケーション別セグメントは次のように区分されます。 ・乳がん、リンパ腫 世界の抗体薬物複合体市場の主要なマーケットプレーヤーは以下のとおりです。 ・ImmunoGen、Seattle Genetics、Roche、Takeda 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 抗体薬物複合体の概要 - タイプ別分析（2017年vs2021年vs2028年）：アドセトリス、カドキュラ - アプリケーション別分析（2017年vs2021年vs2028年）：乳がん、リンパ腫 - 世界の抗体薬物複合体市場規模・予測 - 世界の抗体薬物複合体生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - ImmunoGen、Seattle Genetics、Roche、Takeda ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：アドセトリス、カドキュラ ・アプリケーション別分析2017年-2028年：乳がん、リンパ腫 ・抗体薬物複合体の北米市場分析 - 抗体薬物複合体の北米市場：タイプ別市場規模2017年-2028年 - 抗体薬物複合体の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・抗体薬物複合体のヨーロッパ市場分析 - ：抗体薬物複合体のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：抗体薬物複合体のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・抗体薬物複合体のアジア太平洋市場分析 - 抗体薬物複合体のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 抗体薬物複合体のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・抗体薬物複合体の南米市場分析 - 抗体薬物複合体の南米市場：タイプ別市場規模2017年-2028年 - 抗体薬物複合体の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・抗体薬物複合体の中東・アフリカ市場分析 - 抗体薬物複合体の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 抗体薬物複合体の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antibody-drug Conjugates market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antibody-drug Conjugates market size is estimated to be worth US$ 2913.3 million in 2021 and is forecast to a readjusted size of USD 3964 million by 2028 with a CAGR of 4.5% during review period. Breast Cancer accounting for % of the Antibody-drug Conjugates global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Adcetris segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antibody-drug Conjugates include ImmunoGen, Seattle Genetics, Roche, Takeda, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antibody-drug Conjugates market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Adcetris
Kadcyla
Market segment by Application can be divided into
Breast Cancer
Lymphoma
The key market players for global Antibody-drug Conjugates market are listed below:
ImmunoGen
Seattle Genetics
Roche
Takeda
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody-drug Conjugates product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibody-drug Conjugates, with price, sales, revenue and global market share of Antibody-drug Conjugates from 2019 to 2022.
Chapter 3, the Antibody-drug Conjugates competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody-drug Conjugates breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antibody-drug Conjugates market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody-drug Conjugates.
Chapter 13, 14, and 15, to describe Antibody-drug Conjugates sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Antibody-drug Conjugates Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibody-drug Conjugates Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibody-drug Conjugates Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugates Market Size & Forecast
1.4.1 Global Antibody-drug Conjugates Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antibody-drug Conjugates Sales in Volume (2017-2028)
1.4.3 Global Antibody-drug Conjugates Price (2017-2028)
1.5 Global Antibody-drug Conjugates Production Capacity Analysis
1.5.1 Global Antibody-drug Conjugates Total Production Capacity (2017-2028)
1.5.2 Global Antibody-drug Conjugates Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antibody-drug Conjugates Market Drivers
1.6.2 Antibody-drug Conjugates Market Restraints
1.6.3 Antibody-drug Conjugates Trends Analysis
2 Manufacturers Profiles
2.1 ImmunoGen
2.1.1 ImmunoGen Details
2.1.2 ImmunoGen Major Business
2.1.3 ImmunoGen Antibody-drug Conjugates Product and Services
2.1.4 ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Seattle Genetics
2.2.1 Seattle Genetics Details
2.2.2 Seattle Genetics Major Business
2.2.3 Seattle Genetics Antibody-drug Conjugates Product and Services
2.2.4 Seattle Genetics Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Antibody-drug Conjugates Product and Services
2.3.4 Roche Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business
2.4.3 Takeda Antibody-drug Conjugates Product and Services
2.4.4 Takeda Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antibody-drug Conjugates Breakdown Data by Manufacturer
3.1 Global Antibody-drug Conjugates Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antibody-drug Conjugates Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antibody-drug Conjugates
3.4 Market Concentration Rate
3.4.1 Top 3 Antibody-drug Conjugates Manufacturer Market Share in 2021
3.4.2 Top 6 Antibody-drug Conjugates Manufacturer Market Share in 2021
3.5 Global Antibody-drug Conjugates Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antibody-drug Conjugates Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antibody-drug Conjugates Market Size by Region
4.1.1 Global Antibody-drug Conjugates Sales in Volume by Region (2017-2028)
4.1.2 Global Antibody-drug Conjugates Revenue by Region (2017-2028)
4.2 North America Antibody-drug Conjugates Revenue (2017-2028)
4.3 Europe Antibody-drug Conjugates Revenue (2017-2028)
4.4 Asia-Pacific Antibody-drug Conjugates Revenue (2017-2028)
4.5 South America Antibody-drug Conjugates Revenue (2017-2028)
4.6 Middle East and Africa Antibody-drug Conjugates Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antibody-drug Conjugates Sales in Volume by Type (2017-2028)
5.2 Global Antibody-drug Conjugates Revenue by Type (2017-2028)
5.3 Global Antibody-drug Conjugates Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antibody-drug Conjugates Sales in Volume by Application (2017-2028)
6.2 Global Antibody-drug Conjugates Revenue by Application (2017-2028)
6.3 Global Antibody-drug Conjugates Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antibody-drug Conjugates Sales by Type (2017-2028)
7.2 North America Antibody-drug Conjugates Sales by Application (2017-2028)
7.3 North America Antibody-drug Conjugates Market Size by Country
7.3.1 North America Antibody-drug Conjugates Sales in Volume by Country (2017-2028)
7.3.2 North America Antibody-drug Conjugates Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antibody-drug Conjugates Sales by Type (2017-2028)
8.2 Europe Antibody-drug Conjugates Sales by Application (2017-2028)
8.3 Europe Antibody-drug Conjugates Market Size by Country
8.3.1 Europe Antibody-drug Conjugates Sales in Volume by Country (2017-2028)
8.3.2 Europe Antibody-drug Conjugates Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antibody-drug Conjugates Sales by Type (2017-2028)
9.2 Asia-Pacific Antibody-drug Conjugates Sales by Application (2017-2028)
9.3 Asia-Pacific Antibody-drug Conjugates Market Size by Region
9.3.1 Asia-Pacific Antibody-drug Conjugates Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antibody-drug Conjugates Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antibody-drug Conjugates Sales by Type (2017-2028)
10.2 South America Antibody-drug Conjugates Sales by Application (2017-2028)
10.3 South America Antibody-drug Conjugates Market Size by Country
10.3.1 South America Antibody-drug Conjugates Sales in Volume by Country (2017-2028)
10.3.2 South America Antibody-drug Conjugates Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antibody-drug Conjugates Sales by Type (2017-2028)
11.2 Middle East & Africa Antibody-drug Conjugates Sales by Application (2017-2028)
11.3 Middle East & Africa Antibody-drug Conjugates Market Size by Country
11.3.1 Middle East & Africa Antibody-drug Conjugates Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antibody-drug Conjugates Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antibody-drug Conjugates and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antibody-drug Conjugates
12.3 Antibody-drug Conjugates Production Process
12.4 Antibody-drug Conjugates Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antibody-drug Conjugates Typical Distributors
13.3 Antibody-drug Conjugates Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Antibody-drug Conjugates Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antibody-drug Conjugates Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ImmunoGen Basic Information, Manufacturing Base and Competitors
Table 4. ImmunoGen Major Business
Table 5. ImmunoGen Antibody-drug Conjugates Product and Services
Table 6. ImmunoGen Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table 8. Seattle Genetics Major Business
Table 9. Seattle Genetics Antibody-drug Conjugates Product and Services
Table 10. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Antibody-drug Conjugates Product and Services
Table 14. Roche Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Takeda Basic Information, Manufacturing Base and Competitors
Table 16. Takeda Major Business
Table 17. Takeda Antibody-drug Conjugates Product and Services
Table 18. Takeda Antibody-drug Conjugates Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global Antibody-drug Conjugates Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 20. Global Antibody-drug Conjugates Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in Antibody-drug Conjugates, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global Antibody-drug Conjugates Production Capacity by Company, (Kg): 2020 VS 2021
Table 23. Head Office and Antibody-drug Conjugates Production Site of Key Manufacturer
Table 24. Antibody-drug Conjugates New Entrant and Capacity Expansion Plans
Table 25. Antibody-drug Conjugates Mergers & Acquisitions in the Past Five Years
Table 26. Global Antibody-drug Conjugates Sales by Region (2017-2022) & (Kg)
Table 27. Global Antibody-drug Conjugates Sales by Region (2023-2028) & (Kg)
Table 28. Global Antibody-drug Conjugates Revenue by Region (2017-2022) & (USD Million)
Table 29. Global Antibody-drug Conjugates Revenue by Region (2023-2028) & (USD Million)
Table 30. Global Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
Table 31. Global Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
Table 32. Global Antibody-drug Conjugates Revenue by Type (2017-2022) & (USD Million)
Table 33. Global Antibody-drug Conjugates Revenue by Type (2023-2028) & (USD Million)
Table 34. Global Antibody-drug Conjugates Price by Type (2017-2022) & (USD/Kg)
Table 35. Global Antibody-drug Conjugates Price by Type (2023-2028) & (USD/Kg)
Table 36. Global Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
Table 37. Global Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
Table 38. Global Antibody-drug Conjugates Revenue by Application (2017-2022) & (USD Million)
Table 39. Global Antibody-drug Conjugates Revenue by Application (2023-2028) & (USD Million)
Table 40. Global Antibody-drug Conjugates Price by Application (2017-2022) & (USD/Kg)
Table 41. Global Antibody-drug Conjugates Price by Application (2023-2028) & (USD/Kg)
Table 42. North America Antibody-drug Conjugates Sales by Country (2017-2022) & (Kg)
Table 43. North America Antibody-drug Conjugates Sales by Country (2023-2028) & (Kg)
Table 44. North America Antibody-drug Conjugates Revenue by Country (2017-2022) & (USD Million)
Table 45. North America Antibody-drug Conjugates Revenue by Country (2023-2028) & (USD Million)
Table 46. North America Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
Table 47. North America Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
Table 48. North America Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
Table 49. North America Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
Table 50. Europe Antibody-drug Conjugates Sales by Country (2017-2022) & (Kg)
Table 51. Europe Antibody-drug Conjugates Sales by Country (2023-2028) & (Kg)
Table 52. Europe Antibody-drug Conjugates Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe Antibody-drug Conjugates Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
Table 55. Europe Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
Table 56. Europe Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
Table 57. Europe Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
Table 58. Asia-Pacific Antibody-drug Conjugates Sales by Region (2017-2022) & (Kg)
Table 59. Asia-Pacific Antibody-drug Conjugates Sales by Region (2023-2028) & (Kg)
Table 60. Asia-Pacific Antibody-drug Conjugates Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific Antibody-drug Conjugates Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
Table 63. Asia-Pacific Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
Table 64. Asia-Pacific Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
Table 65. Asia-Pacific Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
Table 66. South America Antibody-drug Conjugates Sales by Country (2017-2022) & (Kg)
Table 67. South America Antibody-drug Conjugates Sales by Country (2023-2028) & (Kg)
Table 68. South America Antibody-drug Conjugates Revenue by Country (2017-2022) & (USD Million)
Table 69. South America Antibody-drug Conjugates Revenue by Country (2023-2028) & (USD Million)
Table 70. South America Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
Table 71. South America Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
Table 72. South America Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
Table 73. South America Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
Table 74. Middle East & Africa Antibody-drug Conjugates Sales by Region (2017-2022) & (Kg)
Table 75. Middle East & Africa Antibody-drug Conjugates Sales by Region (2023-2028) & (Kg)
Table 76. Middle East & Africa Antibody-drug Conjugates Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa Antibody-drug Conjugates Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
Table 79. Middle East & Africa Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
Table 80. Middle East & Africa Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
Table 81. Middle East & Africa Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
Table 82. Antibody-drug Conjugates Raw Material
Table 83. Key Manufacturers of Antibody-drug Conjugates Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Antibody-drug Conjugates Typical Distributors
Table 87. Antibody-drug Conjugates Typical Customers
List of Figures
Figure 1. Antibody-drug Conjugates Picture
Figure 2. Global Antibody-drug Conjugates Revenue Market Share by Type in 2021
Figure 3. Adcetris
Figure 4. Kadcyla
Figure 5. Global Antibody-drug Conjugates Revenue Market Share by Application in 2021
Figure 6. Breast Cancer
Figure 7. Lymphoma
Figure 8. Global Antibody-drug Conjugates Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 9. Global Antibody-drug Conjugates Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Antibody-drug Conjugates Sales (2017-2028) & (Kg)
Figure 11. Global Antibody-drug Conjugates Price (2017-2028) & (USD/Kg)
Figure 12. Global Antibody-drug Conjugates Production Capacity (2017-2028) & (Kg)
Figure 13. Global Antibody-drug Conjugates Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Antibody-drug Conjugates Market Drivers
Figure 15. Antibody-drug Conjugates Market Restraints
Figure 16. Antibody-drug Conjugates Market Trends
Figure 17. Global Antibody-drug Conjugates Sales Market Share by Manufacturer in 2021
Figure 18. Global Antibody-drug Conjugates Revenue Market Share by Manufacturer in 2021
Figure 19. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Antibody-drug Conjugates Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Antibody-drug Conjugates Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Antibody-drug Conjugates Sales Market Share by Region (2017-2028)
Figure 23. Global Antibody-drug Conjugates Revenue Market Share by Region (2017-2028)
Figure 24. North America Antibody-drug Conjugates Revenue (2017-2028) & (USD Million)
Figure 25. Europe Antibody-drug Conjugates Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Antibody-drug Conjugates Revenue (2017-2028) & (USD Million)
Figure 27. South America Antibody-drug Conjugates Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Antibody-drug Conjugates Revenue (2017-2028) & (USD Million)
Figure 29. Global Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
Figure 30. Global Antibody-drug Conjugates Revenue Market Share by Type (2017-2028)
Figure 31. Global Antibody-drug Conjugates Price by Type (2017-2028) & (USD/Kg)
Figure 32. Global Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
Figure 33. Global Antibody-drug Conjugates Revenue Market Share by Application (2017-2028)
Figure 34. Global Antibody-drug Conjugates Price by Application (2017-2028) & (USD/Kg)
Figure 35. North America Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
Figure 36. North America Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
Figure 37. North America Antibody-drug Conjugates Sales Market Share by Country (2017-2028)
Figure 38. North America Antibody-drug Conjugates Revenue Market Share by Country (2017-2028)
Figure 39. United States Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
Figure 43. Europe Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
Figure 44. Europe Antibody-drug Conjugates Sales Market Share by Country (2017-2028)
Figure 45. Europe Antibody-drug Conjugates Revenue Market Share by Country (2017-2028)
Figure 46. Germany Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Antibody-drug Conjugates Revenue Market Share by Region (2017-2028)
Figure 55. China Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
Figure 62. South America Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
Figure 63. South America Antibody-drug Conjugates Sales Market Share by Country (2017-2028)
Figure 64. South America Antibody-drug Conjugates Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Antibody-drug Conjugates Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Antibody-drug Conjugates Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Antibody-drug Conjugates in 2021
Figure 76. Manufacturing Process Analysis of Antibody-drug Conjugates
Figure 77. Antibody-drug Conjugates Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source